Assetmark, Inc
- SEC CIK
- 0001344551
- Latest filing
- Jul 30, 2026
FOLD holding history
Amicus Therapeutics, Inc. in every 13F filed by Assetmark, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −64−100.0% | Sold out | Holders |
| Q2 2025 | 64 | $367 | <0.1% | −14,778−99.6% | Reduced | Holders |
| Q1 2025 | 14,842 | $121.1K | <0.1% | −96,746−86.7% | Reduced | Holders |
| Q4 2024 | 111,588 | $1.05M | <0.1% | −8,499−7.1% | Reduced | Holders |
| Q3 2024 | 120,087 | $1.28M | <0.1% | −39,781−24.9% | Reduced | Holders |
| Q2 2024 | 159,868 | $1.59M | <0.1% | +42,061+35.7% | Added | Holders |
| Q1 2024 | 117,807 | $1.39M | <0.1% | +22,064+23.0% | Added | Holders |
| Q4 2023 | 95,743 | $1.36M | <0.1% | +25,082+35.5% | Added | Holders |
| Q3 2023 | 70,661 | $859.2K | <0.1% | +13,725+24.1% | Added | Holders |
| Q2 2023 | 56,936 | $715.1K | <0.1% | +12,278+27.5% | Added | Holders |
| Q1 2023 | 44,658 | $495.3K | <0.1% | +7,152+19.1% | Added | Holders |
| Q4 2022 | 37,506 | $457.9K | <0.1% | +16,936+82.3% | Added | Holders |
| Q3 2022 | 20,570 | $215.0K | <0.1% | +8,543+71.0% | Added | Holders |
| Q2 2022 | 12,027 | $129.0K | <0.1% | +9,372+353.0% | Added | Holders |
| Q1 2022 | 2,655 | $25.0K | <0.1% | +2,655 | New | Holders |